Safety of Low Dose Intravenous Cangrelor in Acute Ischemic Stroke: A Case Series

Background: Neurointerventional procedures in acute ischemic stroke often require immediate antiplatelet therapy in the cases of acute stenting and occasionally re-occluding vessels. Intravenous cangrelor is a P2Y12 receptor antagonist with short onset and quick offset. The study objective was to ev...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Neurol
Prif Awduron: Salahuddin, Hisham, Dawod, Giana, Zaidi, Syed F., Shawver, Julie, Burgess, Richard, Jumaa, Mouhammad A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2021
Pynciau:
Neurology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8211882/
https://ncbi.nlm.nih.gov/pubmed/34149590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.636682
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg